Glioblastomas (GBMs) are the most frequent and aggressive primary tumors in the
central nervous system owing to their fast clinical course and uniform lethality In the
past decade, there has been a big step forward in the identification of the genomic
and epigenomic alterations found in GBM pa...
Wednesday, 12th, June 2019 - Séminaire Orsay seriesSpeaker(s) : Robert P Fuchs (Marseille Medical Genetics U 1251 AMU/INSERM and BCMP Dept, Harvard Medical School)